| 臺大學術典藏 |
2020-01-06T03:10:49Z |
Phase identification of the new 126 K Ba-Ca-Cu-O superconductor
|
Xue, Y.Y.; Sun, Y.Y.; Rusakova, I.; Ross, D.K.; Du, Z.L.; Wu, N.L.; Cao, Y.; Gao, L.; Hickey, B.; Chu, C.W.; NAE-LIH WU |
| 國家衛生研究院 |
2002-05 |
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients
|
Liu, JM; Chen, LT; Chao, Y; Li, AFY; Wu, CW; Liu, TS; Shiah, HS; Chang, JY; Chen, CT; Wu, HW; Lin, WC; Lan, C; Whang-Peng, J |
| 臺大學術典藏 |
2021-08-31T06:29:23Z |
Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancer
|
Price T.; Shen L.; Ma B.; Esser R.; Chen W.; Gibbs P.; Lim R.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-05-27T05:17:08Z |
Phase II Clinical Trial of Monthly Triptorelin Injection for Prostate Cancer
|
YEONG-SHIAU PU; Jun Chen; Ming-Kuen Lai; Kuei-Li Wu; Yi-Jiun Jou; Teh-Sheng Hsieh; Tsong-Chang Tsai |
| 國立成功大學 |
2016-10 |
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer
|
Scagliotti, Giorgio;Kang, Jin Hyoung;Smith, David;Rosenberg, Richard;Park, Keunchil;Kim, Sang-We;Su, Wu-Chou;Boyd, Thomas E.;Richards, Donald A.;Novello, Silvia;Hynes, Scott M.;Myrand, Scott P.;Lin, Ji;Smyth, Emily Nash;Wijayawardana, Sameera;Lin, Aimee Bence;Pinder-Schenck, Mary |
| 淡江大學 |
2017-10 |
Phase II Monitoring and Diagnosis of Autocorrelated Simple Linear Profiles
|
Wang, Yi-Hua Tina;Huang, Wan-Hsuan |
| 淡江大學 |
2017-05-27 |
Phase II Monitoring and Diagnosis of the Autocorrelated Simple Linear Profiles
|
Wang, Yi-Hua;Huang, Wan-Hsuan |
| 淡江大學 |
2019-12-14 |
Phase II Monitoring of Autocorrelated General Linear Profiles
|
王藝華;賴韻如 |
| 淡江大學 |
2017-05-27 |
Phase II Monitoring of First-Order Autocorrelated General Linear Profiles.
|
Wang, Yi-Hua;Lai, Yunru |
| 國家衛生研究院 |
2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL |
| 臺大學術典藏 |
2014 |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Cheng A.-L.; Yeh K.-H.; Su W.-C.; Chao Y.; Shen Y.-C.; Li C.-P.; Yen C.-J.; CHIUN HSU; Lin Y.-L.; Lin Z.-Z.; Chen L.-T. |
| 國立成功大學 |
2014 |
Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
|
Shen, Ying-Chun; Li, Chung-Pin; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 國立臺灣大學 |
2014 |
Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
|
Shen, Ying-Chun; Li, Chung-Pin; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Cheng, Ann-Lii; 林宗哲; 林育麟; 鄭安理; 許駿; 葉坤輝 |
| 臺大學術典藏 |
2018-09-10T14:50:09Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, Y.-C. and Li, C.-P. and Yen, C.-J. and Hsu, C. and Lin, Y.-L. and Lin, Z.-Z. and Chen, L.-T. and Su, W.-C. and Chao, Y. and Yeh, K.-H. and Cheng, A.-L.; Shen, Ying-Chun;Li, Chung-Pin;Yen, Chia-Jui;Hsu, Chiun;Lin, Yu-Lin;Lin, Zhong-Zhe;Chen, Li-Tzong;Su, Wu-Chou;Chao, Yee;Yeh, Kun-Huei;Cheng, Ann-Lii; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; KUN-HUEI YEH; Shen, Ying-Chun; Shen, Ying-Chun; Li, Chung-Pin; YU-LIN LIN; Li, Chung-Pin; Yen, Chia-Jui; ANN-LII CHENG; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Yu-Lin; Lin, Zhong-Zhe; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L.; Chen L.-T.; Lin Z.-Z.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Chiun Hsu; Lin Y.-L.; Shen Y.-C.;Li C.-P.;Yen C.-J.;Chiun Hsu;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Yeh K.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:34Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.;Li C.-P.;Yen C.-J.;Hsu C.;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Kun-Huei Yeh;Cheng A.-L.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T05:18:32Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Ying-Chun Shen; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:42Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; ZHONG-ZHE LIN; Chen L.-T.; Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:42:27Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-06-10T06:11:05Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; ZHONG-ZHE LIN; Chen L.-T.; Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L. |
| 淡江大學 |
2013-05 |
Phase II profile monitoring based on proportional odds models
|
Longcheen Huwang; Yi-Hua Tina Wang; Arthur B. Yeh; Yi-Heng Huang |
| 國家衛生研究院 |
2007-05 |
Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy
|
Chen, YM;Liu, JM;Chou, TY;Perng, RP;Tsai, CM;Whang-Peng, J |
| 國家衛生研究院 |
2008-01 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy
|
Chou, KT; Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2009-05-20 |
Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan
|
Chen, Y;Tsai, C;Shih, J;Perng, R;Whang-Peng, J |
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer
|
Escudier B; Gr?nwald V; Ravaud A; Ou Y.-C; Castellano D; Chia-Chi Lin; Gschwend J.E; Harzstark A; Beall S; Pirotta N; Squires M; Shi M; Angevin E. |
